Loading...

hVIVO plc

OPORF•PNK
Healthcare
Biotechnology
$0.24
$0.00(0.00%)

hVIVO plc (OPORF) Stock Overview

Explore hVIVO plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap164.9M
P/E Ratio11.40
EPS (TTM)$0.02
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 Week$0.24
1 Month$0.24
3 Months$0.27
1 Year Target$0.20

OPORF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of hVIVO plc (OPORF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.40 and a market capitalization of 164.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-13.45%
6-Month Change
-34.87%
Year-to-Date (YTD) Change
-34.87%
1-Year Change
-31.43%
3-Year Change
4.35%
5-Year Change
12341.68%
All-Time (Max) Change
12341.68%

Contact Information

https://www.hvivo.com
44 20 7756 1300
21 Plumbers Row, London, E1 1EQ

Company Facts

301 Employees
IPO DateJun 5, 2020
CountryGB
Actively Trading

Frequently Asked Questions

;